Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: Characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cells

Matrix Biology

Volumn 15, Issue 6, 1996, Pages 383-395

  Baker, Andrew H ^a,c   Wilkinson, Gavin W G ^a   Hembry, Rosalind M ^b   Murphy, Gillian ^b   Newby, Andrew C ^a,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Adenovirus; Atherosclerosis; Gene transfer; Metalloproteinase; Tissue inhibitor of metalloproteinase

Indexed keywords

GELATIN; METALLOPROTEINASE; RECOMBINANT PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; BREAST ADENOCARCINOMA; CELL STRAIN MCF 7; CONTROLLED STUDY; EMBRYO; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; RABBIT; SMOOTH MUSCLE FIBER; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; CYTOMEGALOVIRUS; MINK CELL FOCUS-FORMING VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 0030483377     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(96)90158-4     Document Type: Article

References (56)

1. Alessandro R., Minafra S., Pucci-Minafra I., Onisto M., Melchiori A., Tetlow L., Woolley D.E. Metalloproteinase and TIMP expression by the human breast carcinoma cell line 8701-BC. Int. J. Cancer. 55:1993;250-255.
2. 2+ mobilization by cAMP and cGMP in rabbit aortic smooth muscle cells. Biochem. J. 288:1992;527-532.
3. Bendeck M.P., Irvin C., Reidy M.A. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ. Res. 78:1996;38-43.
4. Bendeck M.P., Zempo N., Clowes A.W., Gelardy R.E., Reidy M.A. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. 75:1994;539-545.
5. Berkner K.L. Expression of heterologous sequences in adenoviral vectors. Curr. Topics Microbiol. Immunol. 158:1992;39-66.
6. Birkedal-Hansen H., Moore W.G.I., Bodden M.K., Windsor L.J., Birkedal-Hansen B., Decarlo A., Engler J.A. Matrix metalloproteinases: A review. Crit. Rev. Oral Biol. Med. 4:1993;197-250.
7. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49:1983;327-333.
8. Clowes A.W., Clowes M.M., Reidy M.A. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle cell growth in chronically denuded vessels. Lab. Invest. 54:1986;295-303.
9. Clowes A.W., Clowes M.M., Au Y.P.T., Reidy M.A., Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ. Res. 67:1990;61-67.
10. Declerk Y.A., Perez N., Shimada H., Boone T.C., Langley K.E., Taylor S.M. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res. 52:1992;701-708.
11. Docherty A.J.P., Lyons A., Smith B.J., Wright E.M., Stephens P.E., Harris T.J.R., Murphy G., Reynolds J.J. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature. 318:1985;66-69.
12. Fabunmi R.P., Baker A.H., Murray E.J., Booth R.F.G., Newby A.C. Divergent regulation by growth factors and cytokines of 95-kDa and 72-kDa gelatinases and tissue inhibitor of metalloproteinase-1, -2 and -3 in rabbit aortic smooth muscle cells. Biochem. J. 315:1996;335-342.
13. Fridman R., Fuerst T.R., Bird R.E., Hoyhtya M., Oelkuct M., Kraus S., Komarek D., Liotta L.A., Berman M.L., Stetler-Stevenson W.G. Domain structure of human 72-kDa gelatinase/type IV collagenase. J. Biol. Chem. 267:1992;15398-15405.
14. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:1994;2493-2503.
15. George S.J., Fabunmi R.P., Williams A., Newby A.C. Basement-membrane metalloproteinase expression increases during neointima formation in human saphenous vein organ culture. Brit. Heart J. 73:(Suppl 3):1995;84.
16. Goldberg G.I., Marmer B.L., Grant G.A., Eisen A.Z., Wilhelm S., He C.S. Human 72-kDa type IV collagenase forms a complex with tissue inhibitor of metalloproteinases designated TIMP-2. Proc. Natl. Acad. Sci. USA. 86:1989;8207-8211.
17. Graham F.L., Smiley J., Russell C., Nairn R. Characterization of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:1977;59-72.
18. Guzman R.J., Lemarchand P., Crystal R.G., Epstein S.E., Finkel T. Efficient and selective adenoviral-mediated gene transfer into vascular neointima. Circulation. 88:1993;2838-2848.
19. Hembry R.M., Murphy G., Reynolds J.J. Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of specific antiserum. J. Cell Sci. 73:1985;105-119.
20. Howard E.W., Bullen E.C., Banda M.J. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinase-2. J. Biol. Chem. 266:1991;13070-13075.
21. Khoka R., Waterhouse P., Yagel S., Lala P.K., Overall C.M., Norton G., Denhardt D.T. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science. 243:1989;947-950.
22. Koop S., Khokha R., Schmidt E.E., Macdonald I.C., Morris V.L., Chambers A.F., Groom A.C. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res. 54:1994;4791-4797.
23. Lee S.W., Trapnell B.C., Rade J.J., Virmani R., Dichek D.A. In vivo adenoviral-mediated gene transfer into balloon-injured rat carotid arteries. Circ. Res. 73:1993;797-807.
24. Lemarchand P., Jones M., Yamada I., Crystal R.G. In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ. Res. 72:1993;1132-1138.
25. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 284:1980;67-68.
26. Lowenstein, P.R., Shering, A.F., Bain, D., Castro, M.G. and Wilkinson, G.W.G.: How to examine the interactions between adenoviral gene transfer vectors and different identified target brain cell types in vitro. In Gene Transfer into Neurones: Towards Gene Theraphy of Neurological Disorders, ed. by Lowenstein, P.R. and Enquist, L. W., J. Wiley and Sons Ltd, Chichester, U.K. (in press.).
27. MacGregor Gr., Nolan G.P., Fiering S., Roederer M., Herzenberg L.A. Use of E. Coli lac Z (β-galactosidase) as a reporter gene. Murray E.J. Gene Transfer and Expression Protocols. 1992;217-241 Humana Press, Clifton, NJ.
28. McDonnell S., Matrisian L.M. Stromelysin in tumor progression and metastasis. Cancer Met. Rev. 9:1990;305-319.
29. McGrory W.J., Bautista D.S., Graham F.L. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 163:1988;614-617.
30. Meikle M.C., Bord S., Hembry R.M., Reynolds J.J. Rabbit calvarial osteoblasts in culture constitutively synthesize progelatinase-A, and TIMP-1 and TIMP-2. Biochem. Biophys. Acta. 1224:1994;99-102.
31. Montgomery A.M.P., De Clerck Y.A., Langley K.F., Reisfeld R.A., Mueller B.M. Melanoma-mediated dissolution of extracellular matrix: Contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Res. 53:1993;693-700.
32. Murphy G., Reynolds J.J., Hembry R.M. Metalloproteinase and cancer invasion and metastasis. Int. J. Cancer. 44:1989;757-769.
33. Murphy G., Ward R., Hembry R.M., Reynolds J.J., Kuhn K., Tryggvason K. Characterization of gelatinase from pig polymorphonuclear leukocytes. A metalloproteinase resembling tumor type IV collagenase. Biochem. J. 258:1989;463-472.
34. Nabel E.G., Shum L., Pompili V.J., Yang Z.Y., San H., Shu H.B., Liptay S., Gold L., Gordon D., Derynck R., Nabel G.J. Direct transfer of transforming growth factor β1 into arteries stimulates fibrocellular hyperplasia. Proc. Natl. Acad. Sci. USA. 90:1993;10759-10763.
35. Newby A.C., Fabunmi R.P., George S.J., Southgate K.M., Banning A.P., Thurston V.J., Williams A. Fibrosis in vascular pathologies: Role of growth factors and metalloproteinases in vascular smooth muscle proliferation. Exp. Nephrol. 2:1995;108-113.
36. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A laboratory manual. 1989;Cold Spring Harbor Laboratory Press.
37. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
38. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E., Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature. 370:1994;61-65.
39. Southgate K.M., Davies M., Booth R.F.G., Newby A.C. Involvement of extracellular matrix degrading metalloproteinases in rabbit aortic smooth muscle cell proliferation. Biochem. J. 288:1992;93-99.
40. Spessot R., Inchley T.M., Hupel T.M., Bacchetti S. Cloning of herpes simplex virus ICP4 gene in an adenovirus vector: Effects of adenovirus gene expression and replication. Virology. 168:1989;378-387.
41. Stetler-Stevenson W.G., Aznavoorian S., Liotta L. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell. Biol. 4:1993;541-573.
42. Stetler-Stevenson W.G., Brown P.D., Onisto M., Levy A.T., Liotta L.A. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265:1990;13933-13938.
43. Takino T., Sato H., Shinagawa A., Seiki M. Identification of the second membrane-type matrix metalloproteinase (MTMMP-2) gene from a human placenta cDNA library. J. Biol. Chem. 270:1995;23013-23020.
44. Terranova V.P., Hujanen E.S., Martin G.R. Basement membrane and the invasive activity of metastatic tumor cells. J. Natl. Cancer Inst. 77:1986;311-316.
45. Unemori E.N., Hibbs M.S., Amento E.P. Constitutive expression of a 92-kD gelatinase (type IV collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J. Clin. Invest. 88:1991;1656-1662.
46. Uria J.A., Ferrando A.A., Velasco G., Freije J.M.P., Lopez-Otin C. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res. 54:1994;2090-2094.
47. Waller B.F., Pinkerton C.A., Orr C.M., Slack J.D., Vantassel J.W., Peters T. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients. J. Am. Coll. Cardiol. 17:(Suppl. B):1991;33-38.
48. Wang X., Fu X., Brown P.D., Crimmin M.J., Hoffman R.M. Matrix metalloproteinase inhibitor BB-94 (Batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res. 54:1994;4726-4728.
49. Ward R.V., Atkinson S.J., Slocombe P.M., Docherty A.J.P., Reynolds J.J., Murphy G. Tissue inhibitor of metalloproteinase-2 inhibits the activation of 72kDa progelatinase by fibroblast membranes. Biochem. Biophys. Acta. 1079:1991;242-246.
50. Ward R.V., Hembry R.M., Reynolds J.J., Murphy G. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex: Demostration of the biochemical similarities of tissue inhibitor of metalloproteinase-2 and tissue inhibitor of metalloproteinases-1. Biochem. J. 278:1991;179-187.
51. 5 promote adenovirus internalization but not virus attachment. Cell. 73:1993;309-319.
52. Wilhelm S.M., Collier I.E., Marmer B.L., Eisen A.Z., Grant G.A., Goldberg G.I. SV40-transformed human lung fibroblasts secrete a 92 kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264:1989;17213-17221.
53. Wilkinson G.W.G., Akrigg A. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res. 20:1992;2233-2239.
54. Will H., Hinzmann B. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231:1995;602-608.
55. Zempo N., Kenagy R.D., Au T., Bendeck M., Clowes M.M., Reidy M.A., Clowes A.W. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid. J. Vasc. Surg. 20:1994;209-217.
56. Zeng Z.S., Guillem J.G. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Brit. J. Cancer. 72:1995;575-582.